Literature DB >> 15455793

Standard for clinical electroretinography (2004 update).

Michael F Marmor1, Graham E Holder, Mathias W Seeliger, Shuichi Yamamoto.   

Abstract

Mesh：

Year:  2004        PMID： 15455793     DOI： 10.1023/b:doop.0000036793.44912.45

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN： 0012-4486            Impact factor:   2.379


× No keyword cloud information.
  6 in total

1.  Guidelines for basic multifocal electroretinography (mfERG).

Authors:  Michael F Marmor; Donald C Hood; David Keating; Mineo Kondo; Mathias W Seeliger; Yozo Miyake
Journal:  Doc Ophthalmol       Date:  2003-03       Impact factor: 2.379

2.  Guidelines for calibration of stimulus and recording parameters used in clinical electrophysiology of vision.

Authors:  Mitchell Brigell; Michael Bach; Colin Barber; Anne Moskowitz; John Robson
Journal:  Doc Ophthalmol       Date:  2003-09       Impact factor: 2.379

3.  Visual evoked potentials standard (2004).

Authors:  J Vernon Odom; Michael Bach; Colin Barber; Mitchell Brigell; Michael F Marmor; Alma Patrizia Tormene; Graham E Holder
Journal:  Doc Ophthalmol       Date:  2004-03       Impact factor: 2.379

4.  Standard for clinical electro-oculography. International Society for Clinical Electrophysiology of Vision.

Authors:  M F Marmor; E Zrenner
Journal:  Arch Ophthalmol       Date:  1993-05
  6 in total
  205 in total

1.  Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes.

Authors:  Cristina Hernández; Patricia Bogdanov; Cristina Solà-Adell; Joel Sampedro; Marta Valeri; Xavier Genís; Olga Simó-Servat; Marta García-Ramírez; Rafael Simó
Journal:  Diabetologia       Date:  2017-08-04       Impact factor: 10.122

2.  Retinal phenotypes in patients homozygous for the G1961E mutation in the ABCA4 gene.

Authors:  Tomas R Burke; Gerald A Fishman; Jana Zernant; Carl Schubert; Stephen H Tsang; R Theodore Smith; Radha Ayyagari; Robert K Koenekoop; Allison Umfress; Maria Laura Ciccarelli; Alfonso Baldi; Alessandro Iannaccone; Frans P M Cremers; Caroline C W Klaver; Rando Allikmets
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-03       Impact factor: 4.799

3.  Macular vitelliform lesion in desferrioxamine-related retinopathy.

Authors:  Mohamed A Genead; Gerald A Fishman; Anastasios Anastasakis; Martin Lindeman
Journal:  Doc Ophthalmol       Date:  2010-06-09       Impact factor: 2.379

4.  Retinal function in rabbits does not improve 4-5 months after terminating treatment with vigabatrin.

Authors:  Ulrika Kjellström; Sten Kjellström; Anitha Bruun; Sten Andréasson; Vesna Ponjavic
Journal:  Doc Ophthalmol       Date:  2006-01       Impact factor: 2.379

5.  Visual evoked potentials standard (2004).

Authors:  J Vernon Odom; Michael Bach; Colin Barber; Mitchell Brigell; Michael F Marmor; Alma Patrizia Tormene; Graham E Holder
Journal:  Doc Ophthalmol       Date:  2004-03       Impact factor: 2.379

6.  Modulation of rod photoreceptor output by HCN1 channels is essential for regular mesopic cone vision.

Authors:  Mathias W Seeliger; Arne Brombas; Reto Weiler; Peter Humphries; Gabriel Knop; Naoyuki Tanimoto; Frank Müller
Journal:  Nat Commun       Date:  2011-11-08       Impact factor: 14.919

7.  Assessing the impact of non-dilating the eye on full-field electroretinogram and standard flash response.

Authors:  A-M Gagné; J Lavoie; M-P Lavoie; A Sasseville; M-C Charron; M Hébert
Journal:  Doc Ophthalmol       Date:  2010-08-10       Impact factor: 2.379

8.  Cone structure in retinal degeneration associated with mutations in the peripherin/RDS gene.

Authors:  Jacque L Duncan; Katherine E Talcott; Kavitha Ratnam; Sanna M Sundquist; Anya S Lucero; Shelley Day; Yuhua Zhang; Austin Roorda
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-01       Impact factor: 4.799

9.  Four-year placebo-controlled trial of docosahexaenoic acid in X-linked retinitis pigmentosa (DHAX trial): a randomized clinical trial.

Authors:  Dennis R Hoffman; Dianna K Hughbanks-Wheaton; N Shirlene Pearson; Gary E Fish; Rand Spencer; Alison Takacs; Martin Klein; Kirsten G Locke; David G Birch
Journal:  JAMA Ophthalmol       Date:  2014-07       Impact factor: 7.389

10.  Non-selectivity of ERG reductions in eyes treated for retinoblastoma.

Authors:  Catherine Y Liu; Gowtham Jonna; Jasmine H Francis; Brian P Marr; David H Abramson; Scott E Brodie
Journal:  Doc Ophthalmol       Date:  2013-11-09       Impact factor: 2.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.